A KFF poll also suggests half of the respondents who had tried these weight loss meds no longer took them, with many reporting difficulties paying for these drugs.
Compared with standard antihypertensive therapy, intensive antihypertensive therapy may significantly benefit women with T2D whose hypertension is diagnosed earlier in life.
New data find gastric contents after fasting aren't higher than nondiabetics, but an expert endocrinologist disputes that conclusion and GLP-1 agonists further complicate the picture.
A once-daily injectable therapy of a fixed-ratio combination of insulin glargine and lixisenatide improved glycemic control, with low rates of hypoglycemia, in people with T2D in a real-world setting.